Inhibition of Metalloprotease Botulinum Serotype A from a Pseudo-peptide Binding Mode to a Small Molecule That Is Active in Primary Neurons
Open Access
- 1 February 2007
- journal article
- Published by Elsevier BV
- Vol. 282 (7), 5004-5014
- https://doi.org/10.1074/jbc.m608166200
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- Unlabeled uses of botulinum toxins: A review, part 2American Journal of Health-System Pharmacy, 2006
- Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic casesJournal of the American Academy of Dermatology, 2005
- Botulinal neurotoxins: revival of an old killerCurrent Opinion in Pharmacology, 2005
- The evolving field of biodefence: therapeutic developments and diagnosticsNature Reviews Drug Discovery, 2005
- Bacteria as potential tools in bioterrorism, with an emphasis on bacterial toxinsBritish Journal of Biomedical Science, 2005
- Medical aspects of biologic toxinsAnesthesiology Clinics of North America, 2004
- Therapy and prophylaxis of inhaled biological toxinsJournal of Applied Toxicology, 2003
- Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncationMolecular and Cellular Neuroscience, 2003
- Crystal structure of botulinum neurotoxin type A and implications for toxicityNature Structural & Molecular Biology, 1998